ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: STAT5 signaling can promote oncogenesis (99) and hyperactivated STAT5 has been implicated in various leukemia types such as BCR-ABL-induced CML and AML, and in MPDs, such as chronic myelomonocytic leukemia and polycythemia vera (99–101).